Navigation Links
The Arcas Group Appoints Executive Vice President
Date:5/4/2009

ATLANTA, May 4 /PRNewswire/ -- The Arcas Group, a leading life-sciences marketing organization, today announced the appointment of Stefan Terwindt, MBA as Executive Vice President. He will assume responsibility for the commercialization of MDOUTLOOK(R). Mr. Terwindt previously served as President of Imedex, Inc.

"Stefan is an experienced executive who brings great marketing insight, relationships and skills to our company," said Founder and President Jan Heybroek. "I am very pleased that he has joined Arcas to drive the growth of our company."

"It is an amazing opportunity for me to join Jan and his team. We have successfully worked together and built businesses in the past. My focus will be on further developing MDOUTLOOK, our unique, web-based, disease intelligence platform. MDOUTLOOK serves a significant need of life sciences companies by improving their understanding of complex disease areas through proprietary research and analysis methodologies. MDOUTLOOK offers marketers a uniquely detailed insight into physicians' treatment decisions and motivations on a real-time basis," said Mr. Terwindt.

Mr. Terwindt has a 20-year career in continuing medical education, life sciences marketing and international consulting. He is multi-lingual with extensive experience working across cultures, driving change and building successful relationships at all levels within and outside an organization. Mr. Terwindt holds a B.B.A. in International Business and an MBA from the University of Georgia.

About The Arcas Group

The Arcas Group (www.thearcasgroup.com) supports the commercial success of clients in the continuum of life sciences marketing - from marketing intelligence to strategy development and implementation - through enhanced connectivity with ThoughtLeaders and Clinicians.

Arcas serves its clients through three offerings: MDOUTLOOK | Disease Intelligence and ThoughtLeader Insight; Business Optimizer(TM) | Growth Consultancy and Outcome Optimizer(TM) | Medical Strategy Implementation.

Leadership combines more than 80 years of experience in domestic and global life sciences. Our team has worked with over 100 different life science organizations throughout their career, spanning a wide range of therapy and functional areas.

About MDOUTLOOK(R)

MDOUTLOOK has been developed with a singular focus: improved understanding of complex disease areas leading to better patient care. Guided by globally recognized experts, such as Chandra Belani, MD and Giorgio Scagliotti, MD, PhD, MDOUTLOOK delivers clients real-time treatment decisions and rationale, treater profiles and ThoughtLeader analysis via the web (www.mdoutlook.com).

MDOUTLOOK delivers value per this comment from a Group Marketing Director Oncology: "Our analysis showed that MDOUTLOOK was by far the most comprehensive, up-to-date and cost-effective intelligence program available. Its accessibility across many functions in our organization greatly supports our internal knowledge and market understanding. I'm a big fan."

MDOUTLOOK directly collaborates with more than 43,000 cancer treaters in North America and Europe and covers all major and smaller oncology areas, including lung cancer, breast cancer, gastrointestinal cancer, genitourinary cancer, hematological malignancies and melanoma. MDOUTLOOK will be launched shortly in other complex diseases, such as Ophthalmology, Parkinson's Disease, Alzheimer's.

(C) 2009. All rights reserved. MDOUTLOOK, LLC and The Arcas Group, LLC.


'/>"/>
SOURCE The Arcas Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury
2. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
3. Encorium Group Signs Approximately $2.0 Million of New Business Contracts
4. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
5. Mach One BioPharm Process Operating Group Receives Contract From American Beef Processors
6. Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.
7. Disabled and other vulnerable groups more susceptible to terrorism fears
8. ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center
9. Health Strategies Group Expands Focus of Pharma Sales Force Effectiveness Service Under New Vision and Name
10. ChemAxon Launches Marvin and JChem Version 5.2; Web Services, native .NET API, Homology Groups, 3D Alignment and Structural Frameworks
11. GSI Group Inc. to Restate Financial Results for 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... , ... May 19, 2017 , ... ... Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, and who are ... and Delaware, are encouraged to submit proposals. QED, now in its tenth round, ...
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great Point ... continues to grow. CSM has doubled in size over the past six months ... growth strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger has ...
(Date:5/18/2017)... ... May 17, 2017 , ... Cognition ... and commercialization, has just released version 9.0 of the Cognition Cockpit platform. , ... of Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally be ...
(Date:5/18/2017)... ... May 17, 2017 , ... G-CON Manufacturing, ... Chief Executive Officer, Maik Jornitz, was recognized as a Top 10 Industry Influencer ... 100 individuals “involved in bettering the pharma industry and bringing life-changing medicines to ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):